IO Biotech to participate in panel discussion at Biotech Showcase in San Francisco on January 7th

Jan 5, 2019

Copenhagen, Denmark – January 5, 2019: IO Biotech’s CEO, Mai-Britt Zocca, is to participate in the panel discussion “Investing in Next Gen Immunotherapies: Moving the Checkpoint Inhibitors to the Next Level” at Biotech Showcase in San Francisco on January 7, 2019 during the JPM week.

Other news

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Provides Business Update

IO Biotech Provides Business Update